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Abstract
Background: Over the past two decades, genomics has evolved as a scientific research discipline.
Genomics research was fueled initially by government and nonprofit funding sources, later
augmented by private research and development (R&D) funding. Citizens and taxpayers of many
countries have funded much of the research, and have expectations about access to the resulting
information and knowledge. While access to knowledge gained from all publicly funded research is
desired, access is especially important for fields that have broad social impact and stimulate public
dialogue. Genomics is one such field, where public concerns are raised for reasons such as health
care and insurance implications, as well as personal and ancestral identification. Thus, genomics has
grown rapidly as a field, and attracts considerable interest.
Results: One way to study the growth of a field of research is to examine its funding. This study
focuses on public funding of genomics research, identifying and collecting data from major
government and nonprofit organizations around the world, and updating previous estimates of
world genomics research funding, including information about geographical origins. We initially
identified 89 publicly funded organizations; we requested information about each organization's
funding of genomics research. Of these organizations, 48 responded and 34 reported genomics
research expenditures (of those that responded but did not supply information, some did not fund
such research, others could not quantify it). The figures reported here include all the largest
funders and we estimate that we have accounted for most of the genomics research funding from
government and nonprofit sources.
Conclusion: Aggregate spending on genomics research from 34 funding sources averaged around
$2.9 billion in 2003 – 2006. The United States spent more than any other country on genomics
research, corresponding to 35% of the overall worldwide public funding (compared to 49% US
share of public health research funding for all purposes). When adjusted to genomics funding
intensity, however, the United States dropped below Ireland, the United Kingdom, and Canada, as
measured both by genomics research expenditure per capita and per Gross Domestic Product.
Background
Genomics research, as a field of study, is largely a creature
of the past two decades and is generally defined as the
study of whole genomes. The term genomics came into
common use in 1987 to distinguish "high throughput"
data- and technology-intensive approaches to studying
DNA structure and function from the more established
approach of studying DNA structure and function of indi-
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ded in the Human Genome Project and its parallel private
sector components. In 2003, with the completion of a
high-quality sequence of the human genome, the
National Human Genome Research Institute (NHGRI) of
the National Institutes of Health (NIH) announced that
"the genomic era is now a reality" [1]. Genomics has
become central to biomedical and disease-based research;
genomic technologies are being used to identify genetic
factors involved in nine of the ten leading causes of death
in the United States (excluding accidents; [2,3]).
As the social and personal implications of genomics
research have become apparent (its power to identify an
individual uniquely, to influence the health care decisions
of some, and to inform the study of genealogy and ances-
try of individuals and populations), the public has
become increasingly interested in understanding genom-
ics. Genomics is being used in many populations for pur-
poses such as large genome-wide population studies,
personalized genomics, and genomic ancestry tests.
Genomics has become an issue of interest to the general
public, and an element of current culture, as evidenced by
several articles in the popular press [4-11]. As genomics is
incorporated into health care [12], law enforcement [13],
ancestry tracing [14], and other activities, feelings of hope
and fear surrounding individual genomic sequencing
have emerged [15] and public funding allocated to
genomics research has increased [evidenced by the estab-
lishment of the NIH Center for Human Genome
Research, which later became the National Human
Genome Research Institute; [16]].
Most countries provide public funding for scientific
research, under some variation of a mission to promote or
improve the nation's health. Many countries are investing
in genomics as an element of biotechnology, and as a
pathway to economic development. The rise of genomics
funding results from the priority that governments have
placed on such research, which is influenced by policy
decisions. One of the foremost issues in genome research
policy is allocation of funds and research prioritization
[17]. Research prioritization is determined by stakehold-
ers with varying perspectives; therefore each country, and
in fact each organization, is likely to arrive at a different
set of priorities, and subsequent allocation of resources.
The individuals who determine research priorities and
subsequent allocation of funds for each organization are
accountable to the donors who provided funding support;
in the public sector, most research funding is derived from
taxpayer support. Research funding in the United States is
distributed by Congress, whose Members are accountable
to citizens and constituents. As "genomics is beginning to
bring understanding that everyone is at risk for something
based on their genes" [18], public interest in genomics
research increases. Both those advocating for health
research funding to address diseases or health conditions,
and policy-makers who determine government resource
allocations can use information about funding levels to
inform advocacy positions and governmental funding
decisions.
To facilitate its input, the public needs access to data,
benchmarks, and indicators of current research funding,
past funding trends, future projections, and comparisons
with funding organizations around the world. Several
organizations study and publish such data and bench-
marks for general R&D funding or health funding, includ-
ing the R&D Budget and Policy Program of the American
Association for the Advancement of Science (AAAS) [19],
the Division of Science Resources Statistics at the National
Science Foundation (NSF) [20] and its National Science
Board's Science and Engineering Indicators [21], the Sta-
tistics Portal of the Organization for Economic Coopera-
tion and Development (OECD) [22] and the Global
Forum on Health Research [23]. While the authors of
"Monitoring Financial Flows in Health Research" charac-
terize their estimates as "very rough," they remain the best
statistics available on global heath research [24]. Occa-
sional studies have included reporting on genomics
research, including the 2004 "Financial Flows" report [see
Highlight 2.1 (page 27) in [25]], which cited a previous
survey (in 2000) that our current survey builds upon.
There has been no update specific to genomics since 2000
[26], however, so we undertook this "world survey" to
update and expand that survey. We report the allocation
of public funds that countries and organizations in the
public sector (governments, nonprofit organizations, and
international organizations) provide for genomics
research. This survey of public sector funding provides
patterns and trends of worldwide genomics funding,
allowing for initial comparisons across organizations and
countries, and complements an effort to estimate genom-
ics expenditures by private companies [27].
In our survey, we simply asked each organization to pro-
vide a quantitative estimate of the amount of genomics
research they funded each year; we did not supply a defi-
nition of genomics research (because a universally agreed-
upon definition does not exist). To facilitate participation
of as many organizations as possible, we encouraged
organizations to use their own definitions of genomics, so
that funding data could be easily extracted from budget
information. Some funding organizations did not have a
standard definition of genomics research or requested a
specific definition. In those cases, we replied that genom-
ics research is defined by research on the entire genome of
an organism instead of research on individual genes and
gene functions [See Discussion and Chandrasekharan et.Page 2 of 18
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Organizations that were unable to provide estimates for
genomics research were not included in the study. This
survey does not cover all the organizations or all the coun-
tries that publicly fund genomics research. As for any
funding table, there is definitional wobble and incom-
plete reporting. For reasons elaborated below, however,
we believe most of the major sources of public funding
have been identified and that the funding figures pro-
vided here can inform researchers and policymakers on
the state of genomics research, at least as rough indicators
and for information about trends.
Results
For this world survey of genomics research, we identified
89 different organizations, representing 26 countries and
7 international organizations (covering multi-country
regions; see Additional File). An initial response was
received from about half (42; or 48 if counting those that
we did not contact but about which we received informa-
tion), with most of those (34) supplying the results
shown in Table 1. The 14 organizations that responded to
our request but did not provide information cited reasons
such as the information not being available in the format
requested (i.e. they were unable to estimate funding allo-
cated to genomics research) or that genomics was not a
part of their research portfolio.
An estimate for worldwide genomics funding from the
responding organizations averages around US$2.9 billion
for 2003 – 2006 (Table 1). Although the table is incom-
plete for 2006 due to unavailability of funding amounts
for South Africa's National Research Foundation and
China, their combined total averaged less than three per-
cent of worldwide government and nonprofit genomics
research in 2003 – 2005.
When beginning this survey, we noted that the United
States NIH publicly reported an estimate of funding for
the research area of genetics [28]. To find out more about
this reporting practice, we requested and received the
breakdown of genetics research funding by NIH compo-
nent (Table 2; Personal Communication, Arlette Howard,
May 2006). In an effort to determine whether the NIH
considered genomics research to be a subset of genetics
research, we requested the definition of genetics research
from the Office of Budget and found that the NIH does
"not have an official definition" (Personal Communica-
tion, Arlette Howard, May 2006). Turning to each of the
24 grant-issuing Institutes and Centers of the NIH, we
requested information about their definitions for genetics
and genomics research. Except for the National Cancer
Institute (NCI) and the NHGRI, discussed below, each
Institute and Center informed us that they did not have a
definition for genetics, and that they do not track genom-
ics research funding.
The NCI provided a definition for both genetics and
genomics, and informed us that fiscal year 2006 marked
the first year of data collection on genomics research (Per-
sonal Communication, Weston Ricks, June 2006). In fis-
cal years 2006 and 2007, NCI genomics research funding
corresponded to 7.0% and 10.2% of genetics funding,
respectively (Personal Communication, Weston Ricks,
July 2008), as indicated in Table 3. To estimate the
amount of genomics research funded by NCI in fiscal
years 2003 – 2005, we applied the average fraction from
2006 – 2007 (8.6%) to the amount of genetics funding
(Table 3). Upon examining the funding history of NHGRI
[29], we observed that the NHGRI genetics values from
the NIH Office of Budget (Table 2) corresponded to the
amount of the NHGRI total budget, less Roadmap Trans-
fer, and Research Management & Support. Since this value
also corresponds to Intramural Research plus all (Extra-
mural) Research, Training, and R&D Contracts for Human
Genome Project [29], and since its mission "encompasses
a broad range of studies aimed at understanding the struc-
ture and function of the human genome and its role in
health and disease" [30], this amount appears to be the
figure that NHGRI reports as genomics research, reflected
in Table 3. Although other Institutes and Centers support
genomics research, they do not report the values, so we
present the values from NCI and NHGRI as a minimum
estimate for NIH spending on genomics research
(US$563 – 571 million in 2003 – 2006).
The 34 organizations in the survey account for 13 coun-
tries directly, as well as indirectly including another 28
countries that are eligible for full funding by the European
Commission (27 member states of the European Union
plus Iceland, Norway, Liechtenstein, Switzerland, Israel,
and Turkey; Personal Communication, Indridi Benediktt-
son, September 2006). Only five of the thirty-three coun-
tries fully eligible for European Commission funding are
directly represented in this world survey (the United King-
dom, the Netherlands, Germany, Ireland, and Spain). Of
note, funds from the European Commission cover about
50% of the costs of the funded projects; the remaining
costs are covered by each institution that receives funding
(Personal Communication, Indridi Benedikttson, Sep-
tember 2006), which are included in Table 1 as European
Commission matching funds.
We grouped the organizations by country (Table 4) into
three tiers based on the amount of genomics research
funded. The five countries or regions that funded more
than US$100 million in genomics research in each of the
four years surveyed are the United States, Other Europe,
the United Kingdom, Canada, and Japan. The next tierPage 3 of 18
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Rank Organization 2003 2004 2005 2006 Source
n/a Department of Health and Human Services (DHHS) 
National Institutes of Health (NIH) – GENETICSO
$4236 $4535 $4840 $4878 [28]
1 NIH: National Cancer Institute (NCI) + National Human 
Genome Research Institute (NHGRI)
$562 $593 $593 $571 See Tables 2, 3 and text
2 European CommissionJ $459 $462 $466 $468 Personal Communication, Indridi 
Benediktsson, September 2006
3 European Commission Matching FundsJ $459 $462 $466 $468 Personal Communication, Indridi 
Benediktsson, September 2006
4 United Kingdom Wellcome TrustO $194 $194 $208 $199 [52,53]
5 Department of Energy (DOE) Office of Biological and 
Environmental ResearchO
$129 $152 $154 $158 [33-36]
6 National Science Foundation (NSF) Biological Sciences 
DirectorateO
$124 $129 $134 $141 Personal Communication, Vernon 
Ross, April 2007
7 Japan Ministry of Education, Culture, Sports, Science and 
Technology (MEXT)A
$84.5 $99.2 $119 $125 Personal Communication, Kazuko 
Shinohara, January 2007
8 United Kingdom Biotechnology and Biological Sciences 
Research Council (BBSRC)A
$121 $127 $128 $117 Personal Communication, Clare Nixon, 
January 2007
9 Genome CanadaA $67.3 $65.7 $71.6 $106 Personal Communication, Genny 
Cardin, July 2006
10 China (Ministry of Science and Technology, National 
Natural Science Foundation of China, and Chinese 
Academy of Sciences)J
$80 $80 $80 no report Personal Communication, Anonymous, 
October 2007
11 Germany Nationales Genomforschungsnetz (NGFN)J $71.6 $61.4 $62.0 $64.8 Personal Communication, Uta Strasser, 
September 2006
12 Department of Defense (DOD) Congressional Directed 
Medical Research Programs (CDMRP)O
$102 $86.8 $53.5 $54.9 [45]
13 Cancer Research UKA $34.1 $45.2 $48.1 $51.0 Personal Communication, Lynne 
Davies, January 2007
14 Netherlands Genomics InitiativeJ $48.8 $18.1 $51.7 $45.8 [31,87,88]
15 South Korea Ministry of Science and Technology 
(MOST)J
$39.7 $35.0 $41.5 $44.3 Personal Communication, Jeongheui 
Lim, January 2007
16 United States Department of Agriculture (USDA) 
Agricultural Research ServiceO
$32.5 $38.8 $41.9 $43.1 Personal Communication, Peggy 
DelCollo and Joe Garbarino, 
November 2006
17 Ireland Higher Education AuthorityJ $34.1 $34.7 $34.5 $34.5 Personal Communication, Sorcha 
Carthy, August 2006
18 Canada Natural Sciences and Engineering Research 
Council (NSERC)A
$28.2 $30.4 $32.2 $34.1 Personal Communication, Barney 
Laciak, October 2007
19 Department of Homeland Security (DHS)O $13.4 $25.9 $32.8 $27.2 Personal Communication, Elizabeth 
George, November 2006Page 4 of 18
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and Ireland, which reported between US$35 – 80 million
in genomics research funding each year (with the excep-
tion of 2004 for the Netherlands, which was lower than
the other years because expenditures were "declared
(much) later" [31]). Finally, Spain, Australia, and South
Africa reported less than US$14 million each year.
To examine the priority each country places on genomics
research, as a measure of "genomics intensity," we nor-
20 Japan Ministry of Agriculture, Forestry and Fisheries 
(MAFF)A
$17.9 $22.9 $21.7 $21.7 Personal Communication, Kazuko 
Shinohara, January 2007
21 Canadian Biotechnology Strategy (CBS)A $16.1 $15.9 $15.9 $16.2 [55]
22 Howard Hughes Medical Institute (HHMI)J $15.2 $13.8 $14.3 $15.6 Personal Communication, Sherry 
White, August 2006
23 Canada National Research Council (NRC) Genomics and 
Health InitiativeA
$18.2 $15.8 $13.4 $15.3 Personal Communication, Gary Fudge, 
August 2007
24 Japan Ministry of Health, Labour and Welfare (MHLW)A $12.8 $13.8 $18.6 $14.9 Personal Communication, Kazuko 
Shinohara, January 2007
25 American Cancer SocietyJ $5.95 $6.90 $5.61 $11.9 Personal Communication, Donella 
Wilson, July 2006
26 Spain Genoma EspanaJ $9.98 $12.1 $13.5 $11.7 Personal Communications, Javier 
Montero Plata, June and September 
2006
27 Australia National Health and Medical Research Council 
(NHMRC) *
$7.54 $6.34 $6.24 $7.65 Personal Communication, Marian 
Blake, July 2006
28 Department of Health and Human Services (DHHS) 
Centers for Disease Control and Prevention (CDC)O
$3.85 $4.53 $6.99 $6.95 [37,38]
29 Department of Defense (DOD) Defense Advanced 
Research Projects Agency (DARPA) Bio/Info/Micro 
ProgramO
$34.0 $13.4 $13.2 $6.5 [41-44]
30 South African Medical Research CouncilJ $1.73 $1.84 $2.04 $2.24 Personal Communication, Clive Glass, 
October 2007
31 Ireland Science FoundationJ $7.41 $7.96 $1.38 $2.24 Personal Communication, Tracy 
Moloney, September 2006
32 Ireland Health Research BoardJ $1.29 $2.23 $1.50 $1.61 Personal Communication, Gillian 
Hastings, January 2007
33 South Africa National Research FoundationJ $0.658 $0.560 $0.999 no report Personal Communication, Marna van 
Rooyen, October 2006
34 Japan Ministry of Economy, Trade and Industry (METI)A $0 $4.51 $0 $0 Personal Communication, Kazuko 
Shinohara, January 2007
TOTAL $2834 $2878 $2948 $2881
Genomics research funded, by organization, is shown in millions of US$ per year. The total funding values each year were determined by summing 
the values from each organization, with the exception of the first row (NIH – Genetics), which is described in the text. Rankings were determined 
by ordering the 2006 values, where the average of the three previous years was used as a substitute for 2006 values when the actual 2006 data was 
unavailable. The start of each fiscal year is indicated by the superscript character after each organization, where J = January 1, A = April 1, and O = 
October 1.
*Although the fiscal year for the Australian government begins July 1, the original data was reported by calendar year.
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Fiscal Year 2003 Fiscal Year 2004 Fiscal Year 2005 Fiscal Year 2006, Est Fiscal Year 2007, Bdgt
National Cancer Institute $1,275,213 $1,364,851 $1,451,384 $1,451,384a $1,435,419a
National Human Genome
Research Institute
$453,105 $475,735 $468,049 $463,900 $459,039
National Institute of General
Medical Sciences




$354,940 $400,140 $416,474 $414,113 $409,972
National Institute of Child
Health and Human
Development
$308,304 $320,310 $329,252 $329,600 $329,400
National Institute of Mental
Health
$194,484 $201,564 $239,907 $237,849 $235,625
National Heart, Lung and
Blood Institute
$253,240 $229,478 $230,335 $231,487 $232,644




$169,231 $201,603 $199,125 $197,532 $195,754
National Eye Institute $176,028 $182,542 $198,605 $197,413 $195,242
National Center for
Research Resources
$157,993 $163,381 $165,859 $167,551 $166,890
National Institute of Dental
and Craniofacial Research




$105,805 $108,196 $111,369 $110,255 $109,263
National Institute of Arthritis
and Musculoskeletal
Disorders




$51,474 $52,253 $57,266 $56,715 $56,170
National Institute on Drug
Abuse
$39,142 $48,858 $52,036 $51,724 $51,465




$9,157 $9,932 $8,975 $8,885 $8,823
Office of the Director $2,338 $7,085 $5,165 $4,754 $4,764Page 6 of 18
(page number not for citation purposes)
BMC Genomics 2008, 9:472 http://www.biomedcentral.com/1471-2164/9/472malized public funding for genomics research to the
national population (Table 5) and to Gross Domestic
Product (GDP; Table 6). Ireland spent approximately
US$9 – 11 on genomics research per capita while the
United Kingdom, Canada, the United States, and the
Netherlands funded between US$2.8 – 6.4 per capita each
year (with the exception of 2004 for the Netherlands, see
above). Japan, South Korea, and Germany spent between
US$0.70 – 1.30 annually per capita on genomics, while
the remaining four countries surveyed (Australia, Spain,
South Africa, and China) spent less than US$0.38 annu-
ally per capita. Genomics funding as a fraction of GDP
shows the same relative ranking as genomics funding per
capita for the first five countries, followed by South Korea,
Japan, China, Germany, South Africa, Australia, and Spain
(Table 6).
Discussion
This survey does not cover all the organizations or coun-
tries that publicly fund genomics research. To estimate
how well the values reported in this survey correspond to
the actual public funding of genomics research in each
country, we determined, where possible, the research
funders for each country that were not included in this
survey (see Additional File 1).
National Institute of Nursing
Research
$5,642 $4,600 $3,537 $3,509 $3,477
Fogarty International Center $3,712 $2,905 $1,978 $1,978 $1,978
National Center on Minority
Health and Health Disparities




National Institute of Allergy
and Infectious Diseases
National Institute of
Diabetes and Digestive and
Kidney Disorders
National Library of Medicine
Total NIH Genetics $4,235,759 $4,534,771 $4,839,864 $4,822,235b $4,780,055b
The amount of genetics research funded by NIH components (24 grant-issuing Institutes and Centers, the Office of the Director, and the Roadmap) 
is indicated in thousands of US$; Fiscal year 2006 is an estimate, and fiscal year 2007 is the President's budget. The values in this table were provided 
by the NIH Office of Budget (Personal Communication, Arlette Howard, May 2006).
a NCI actual genetics funding for fiscal years 2006 and 2007 was $1,530,200 and $1,523,628, respectively, in thousands (Personal Communication, 
Weston Ricks, July 2008).
b Total NIH Genetics funding (actual) for fiscal years 2006 and 2007 was $4,878,000 each year, in thousands [28].
Table 2: Genetics Funding by the National Institutes of Health, in US$ (thousands) (Continued)
Table 3: Genomics Funding by the National Institutes of Health, in US$ (thousands)
FY 2003 FY 2004 FY 2005 FY 2006 FY 2007
National Cancer Institute (NCI)c $109,598 $117,302 $124,739 $107,413 $154,944
National Human Genome Research Institute (NHGRI)d $453,105 $475,735 $468,049 $463,550 $468,232
NCI+NHGRI $562,703 $593,037 $592,788 $570,963 $623,176
The amount of genomics research funded by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), in 
thousands of US$, where FY = fiscal year.
c NCI values for fiscal years 2006 and 2007 were 7.02% and 10.17% of genetics funding, respectively (Personal Communication, Weston Ricks, July 
2008). We estimated the values for fiscal years 2003 – 2005 by multiplying the genetics funding values for each year by the average ratio of 
genomics:genetics funding for fiscal years 2006 – 2007.
d We determined NHGRI values as the total NHGRI funding appropriation minus Roadmap Transfer and Research Management & Support [[29]; 
see text].Page 7 of 18
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United States
The United States funded about one third of the genomics
research reported in this world survey for 2003 – 2006
(Figure 1 for 2006; compared to 49% of worldwide gov-
ernment and nonprofit funding for health research in
2001 [25]). The amount of funding and funding per cap-
ita rose slightly in 2004 but decreased in 2005 and 2006
(Table 4, Table 5 and Figure 2), while funding per GDP
steadily decreased (Table 6 and Figure 3).
Over half of the United States contribution was provided
by the NIH. As described above, we made considerable
effort to determine the amount of genomics research
funding by each Institute and Center, but we were only
able to quantitate NCI and NHGRI directly. In these two
cases, the amount of genomics research compared to
genetics research was just under 10% (NCI) and 100%
(NHGRI). Actual kinds of research undoubtedly differ
between NCI and NHGRI, but a significant portion of the
difference is likely attributable to different definitions and
reporting practices for "genomics" as a category. If other
Institutes and Centers fund genomics in proportion to
genetics research similar to the NCI proportion, the addi-
tional genomics expenditure (for the Institutes and Cent-
ers that reported Genetics funding) would total $215 –
250 million in Table 2.
Although the NIH funded US$4.2 – 4.9 billion of genetics
research (about 16 – 17% of the total NIH budget, and the
sixth or seventh most funded research area of 210 catego-
ries, [28]) we note missing data from four grant-issuing
Institutes and Centers (National Center on Complemen-
tary and Alternative Medicine, National Institute of
Allergy and Infectious Diseases, National Institute of Dia-
betes and Digestive and Kidney Disorders, and National
Library of Medicine; Table 2). A simple query of CRISP
(Computer Retrieval of Information on Scientific
Projects), a searchable database of biomedical research
projects funded by the NIH and other Department of
Health and Human Services (DHHS) components, reveals
that each of these NIH components does fund genetics
Table 4: Genomics funding by country or region, in US$
Rank Country 2003 2004 2005 2006
1 United States $1,023,269,552 $1,064,204,394 $1,049,343,544 $1,035,309,134
n/a Other Europe $918,484,501 $923,787,529 $931,315,483 $936,768,150
2 United Kingdom $349,339,913 $366,753,082 $384,375,015 $366,638,731
3 Canada $124,919,355 $122,960,000 $128,400,000 $166,260,163
4 Japan $115,289,855 $140,488,722 $159,359,375 $161,451,613
5 China $80,000,000 $80,000,000 $80,000,000 $0*
6 Germany $71,602,210 $61,409,396 $61,947,905 $64,800,000
7 Netherlands $48,775,731 $18,127,090 $51,743,764 $45,793,541
8 South Korea $39,713,000 $35,000,000 $41,495,000 $44,341,000
9 Ireland $42,841,306 $44,848,081 $37,366,395 $38,332,844
10 Spain $9,981,553 $12,079,692 $13,544,247 $11,668,897
11 Australia $7,547,002 $6,386,677 $6,243,976 $7,655,910
12 South Africa $2,388,907 $2,397,169 $3,037,712 $2,238,932*
The amount of genomics research funded by each country or region is indicated in US$. The region "Other Europe" refers to funding in European 
countries for which the table does not directly account (i.e. excludes the funding in other rows of the table that was supplied directly from public 
funds in the listed European countries), and thus is not included in the rank. Rankings were determined by ordering the 2006 values, where the 
average of the three previous years was used as a substitute for 2006 values when the actual 2006 data was unavailable. Data is reported by fiscal 
year, as indicated in Table 1.
* The 2006 data is incomplete because of missing information from the South African National Research Foundation or from China's research 
organizations.Page 8 of 18
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genetics research is likely to be higher than that reported by
NIH, and the additional amount of genomics research
could be much more than $215 – 250 million.
The Department of Energy (DOE) Office of Biological and
Environmental Research funded genomics research in the
Life Sciences funding category under the subcategories of
Microbial Genomics, Genomics: GTL [Genomes To Life
program], Human Genome, and Functional Genomics/
Health Effects [33-36]. The NSF Biological Sciences Direc-
torate funded genomics research under the following
three programs: Microbial Genome Sequencing Program,
the Plant Genome Project, and the 2010 Project (Personal
Communication, Vernon Ross, April 2007).
Genomics funding from the Centers for Disease Control
and Prevention (CDC) increased from US$3.85 million
(2003) to US$6.95 million (2006) [37,38]; part of this
increase was due to a change in budget structure in 2005,
when genomics funding moved from environmental
health to health promotion, with slightly different con-
ventions in calculating funding values (Personal Commu-
nication, Sara Schmit, July 2006). The United States
Department of Agriculture (USDA) funded genomics
research projects through the Agricultural Research Serv-
ices (Personal Communication, Peggy Del Collo and Joe
Garbarino, November 2006). The DHS supported genom-
ics research through the Science and Technology Directo-
rate (Personal Communication, Elizabeth George,
November 2006). The Howard Hughes Medical Institute
(HHMI) funded genomics research through its Science
Department at US$13 – 15 million (Personal Communi-
cation, Sherry White, August 2006). The American Cancer
Society provided between US$6 – 12 million in genomics
research funding (Personal Communication, Donella
Wilson, July 2006).
The US Department of Defense supports research and
development through the Defense Advanced Research
Projects Agency (DARPA), which pursues research and
technology where risk and payoff are both very high [39],
and through the United States Army with the Congres-
Table 5: Genomics funding per capita by country, in US$
Rank Country 2003 2004 2005 2006
1 Ireland $10.77 $11.09 $9.05 $9.13
2 United Kingdom $5.87 $6.13 $6.41 $6.06
3 Canada $3.94 $3.85 $3.98 $5.10
4 United States $3.52 $3.62 $3.54 $3.46
5 Netherlands $3.01 $1.11 $3.17 $2.79
6 Japan $0.90 $1.10 $1.25 $1.26
7 South Korea $0.83 $0.73 $0.96 $0.91
8 Germany $0.87 $0.74 $0.75 $0.79
9 Australia $0.38 $0.32 $0.31 $0.37
10 Spain $0.24 $0.28 $0.31 $0.26
11 South Africa $0.05 $0.05 $0.06 $0.05*
12 China $0.06 $0.06 $0.06 $0.00*
The amount of genomics research funded per capita by each country 
or region is indicated in US$. Rankings were determined by ordering 
the 2006 values, where the average of the three previous years was 
used as a substitute for 2006 values when the actual 2006 data was 
unavailable. Data is reported by fiscal year, as indicated in Table 1.
* The 2006 data is incomplete because of missing information from 
the South African National Research Foundation or from China's 
research organizations.
Table 6: Genomics funding per GDP by country (×100,000)
Rank Country 2003 2004 2005 2006
1 Ireland 27.27 24.44 18.61 17.48
2 United Kingdom 19.25 17.02 17.24 15.55
3 Canada 14.38 12.37 11.34 13.06
4 United States 9.34 9.09 8.42 7.81
5 Netherlands 9.04 2.98 8.21 6.91
6 South Korea 6.53 5.15 5.27 5.05
7 Japan 2.72 3.06 3.49 3.62
8 China 4.88 4.14 3.58 0.00*
9 Germany 2.93 2.24 2.22 2.24
10 South Africa 1.44 1.12 1.27 0.87*
11 Australia 1.43 1.00 0.88 1.03
12 Spain 1.13 1.16 1.20 0.96
The amount of genomics research funded per GDP by each country 
or region is indicated in US$ (× 100,000 for ease of comparison). 
Rankings were determined by ordering the 2006 values, where the 
average of the three previous years was used as a substitute for 2006 
values when the actual 2006 data was unavailable. Data is reported by 
fiscal year, as indicated in Table 1.
* The 2006 data is incomplete because of missing information from 
the South African National Research Foundation or from China's 
research organizations.Page 9 of 18
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[40]. DARPA sponsored genomics research under the Bio/
Info/Micro Sciences programs: Biocomputational Systems
and Bio Interface, and the Comparative Genomics for
National Security Goals [41-44]. We used the online data-
base of the Congressionally Directed Medical Research
Program to determine the funding for genomics research
by searching for awards that were classified in the
"genomics and proteomics" research topic (2003 and
2004) or the "genomics" research topic (2005 and 2006)
or awards that listed "genom%" in the abstract, where% is
a wild character [45].
To estimate the completeness of the United States spend-
ing on genomics research reported here, we determined
the percentage of federal and nonprofit funding on R&D
that is covered by the entities in this survey. Of the
US$1,023 – 1,064 million per year in federally funded
research and development in all disciplines (2003 –
2006), six of the entities included in this survey (DOD,
DOE, NIH, NSF, USDA, and DHS) accounted for 84 –
86% [46]. Although we were unable to determine the per-
centage of total research and development funds provided
by the nonprofits listed in our survey, the overall contri-
bution of nonprofits towards total research and develop-
ment funding in the US was 3% in 2004 [47]. Combined,
these two data indicate that there are unlikely to be major
public funders in the United States that are not addressed
in this survey, and that the survey accounts for a large
majority of total genomics government and nonprofit
expenditures in the United States. The remaining public
funds for genomics research are likely to be attributable to
the government and nonprofit funders identified in this
survey that did not supply data, such as the four NIH Insti-
tutes and Centers named above, the National Aeronautics
and Space Administration (NASA) Ames Center, National
Institutes of Standards and Technology (NIST), National
Oceanic and Atmostpheric Administration (NOAA), the J.
Percent of Worldwide Genomics Research Publicly Funded by Country/Region in 2006Figure 1
Percent of Worldwide Genomics Research Publicly Funded by Country/Region in 2006. The percent of worldwide 
genomics funding provided by each identified country or region is depicted graphically for 2006, except for South Africa and 
China, where the average of the three previous years was used as a substitute for 2006 values, since 2006 data was unavailable.Page 10 of 18
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Research (TIGR), and the Bill & Melinda Gates Founda-
tion.
European Union
The European Commission funds genomics research in
the European Union, plus Iceland, Norway, Liechtenstein,
Switzerland, Israel, and Turkey. In the Sixth Framework
Programme of the European Commission, covering 2002
– 2006, the major funding areas that included genomics
research were Advanced Genomics and its Applications
for Health, and Combating Major Diseases [Personal
Communication, Indridi Benediktsson, September 2006;
[48]]. European Commission funds, including matching
funds, provided about 32% of worldwide public genom-
ics research funding in 2006 (Figure 1). Recently, a new
European agency was created (the European Research
Council) that will be an "independent, quality-driven
funding body run by the scientists themselves" [49] and
will likely increase the public funding of genomics (along
with other types of scientific) research in Europe.
In an effort to include the European countries funded
through the European Commission but not otherwise
covered in this world survey, we contacted organizations
from Austria (Fonds zur Forderung der Wisenschaftlichen
Forschung), Denmark (Ministry of Science, Technology
and Innovation), Estonia (Estonian Genome Founda-
tion), Finland (Academy of Finland), France (Association
Francaise Contre les Myopathies, La Recherche
Agronomique au Service des Pays du Sud, Centre National
de la Recherche Scientique, GenHomme, l'Institut
National de la Recherche Agronomique, Institut Pasteur,
and Institut de Recherche pour le Developpement), Hun-
gary (National Office for Research and Technology), Ice-
land (Rannis), Italy (Agenzia Spaziale Italiana), Poland
(Ministry of Scientific Research and Information Technol-
ogy), and Sweden (Knut and Alice Wallenberg Founda-
Public Genomics Funding per CapitaFigure 2
Public Genomics Funding per Capita. Genomics funding per capita for 2003 – 2006, as shown in Table 5, is depicted 
graphically.Page 11 of 18
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except for the Academy of Finland and Centre National de
la Recherche Scientique (see Additional File 1), both of
which provided an initial response before communica-
tion ceased. We also contacted several international
organizations active in Europe (European Space Agency,
NordForsk, and the Human Frontier Science Program),
but were unsuccessful in gathering funding data.
United Kingdom
Spending on genomics research in the United Kingdom
decreased slightly in 2006, after a steady increase from
2003 to 2005 (Table 4). The United Kingdom was the sec-
ond highest funder of genomics research per capita and
per GDP (Tables 5 and 6); both measures of genomics
"intensity" declined in 2006 (Figures 2 and 3). The three
United Kingdom public funders in this survey are Cancer
Research UK, the Wellcome Trust, and the Biotechnology
and Biological Sciences Research Council (BBSRC), each
of which allocated at least 10% of its research monies for
genomics. An analysis of the annual reports of the BBSRC
shows that 35 – 40% of the total research funded (through
responsive research grants, core strategic grants, and
research initiatives) was genomics [50,51]. Similarly, the
Wellcome Trust reported spending 29 – 38% of its grant
expenditures on genomics research [52,53]. Finally, the
genomics research funded by Cancer Research UK was
estimated at 10% of its charitable expenses (Personal
Communication, Lynne Davies, January 2007).
Canada
Canada supplied about 6% of total genomics research
funding in 2006 (Figure 1), which increased significantly
from a relatively constant contribution in 2003 – 2005
(Table 4). Likewise, the genomics intensity measures
(genomics funding per capita and per GDP) increased in
2006 (Tables 5 and 6). Its public funding on genomics
research is likely to continue increasing, since it recently
began a new initiative, the Public Population Project in
Genomics [54].
Public Genomics Funding per GDP (×100,000)Figure 3
Public Genomics Funding per GDP (×100,000). Genomics Funding per GDP for 2003 – 2006, as shown in Table 6, is 
depicted graphically.Page 12 of 18
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Genome Canada, the Natural Sciences and Engineering
Research Council (NSERC) of Canada, the National
Research Council (NRC) and the Canadian Biotechnology
Strategy (CBS). The CBS includes six departments and
agencies that are building capacity for new research (Agri-
culture and Agri-Food Canada, Department of Fisheries &
Oceans, Department of Natural Resources Canada, Envi-
ronment Canada, Health Canada, and National Research
Council (NRC) [55]), although the contribution from
NRC (Canadian $6 million per year) was reduced to avoid
double-counting of NRC-funded genomics research (Per-
sonal Communication, Gary Fudge, October 2007).
Other public funders of genomics research include the
Canadian Institutes of Health Research (formerly the
Medical Research Council), the Canada Foundation for
Innovation, and the Social Sciences and Humanities
Research Council, none of these responded to the survey.
Japan
Japan's spending on genomics research steadily increased
between 2003 and 2006, when it reached 5% of world-
wide public funding (Table 4 and Figure 1). Although its
ranking dropped from fourth (Table 4) to sixth or seventh
when adjusted for intensity (Tables 5 and 6), genomics
research is increasing by all measures, indicating that may
be poised to overtake some countries in the coming years.
In fact, the Second Science and Technology Basic Plan
(2001 – 2005) was intended to close the gap between
Japan and the other G7 nations in the percentage of R&D
funding provided by government. The Third Science and
Technology Basic Plan, which began in 2006, has a goal to
increase overall government funding of R&D until the Sci-
ence and Technology investment equals 1% of Japan's
GDP [56].
The values reported in this world survey for Japan are
likely a near-complete representation of the government's
investment in genomics, since the four Japanese minis-
tries reported in this survey (Ministry of Economy, Trade
and Industry [METI], Ministry of Education, Culture,
Sports, Science and Technology [MEXT], Ministry of Agri-
culture, Forestry and Fisheries [MAFF], and the Ministry of
Health, Labour and Welfare [MHLW]) are the main gov-
ernment funders of life science and genomics research
[57-60]. One nonprofit organization, Kazusa DNA
Research Institute, was identified and contacted, but did
not respond to the survey.
China
Our source for China indicated that the central govern-
ment funded about US$40 million per year of genomics
research through the National Natural Science Founda-
tion of China (NSFC), the Chinese Academy of Sciences
(CAS), and two programs at the Ministry of Science and
Technology (MOST): the National High-tech Develop-
ment R&D Program (863 Program) and the National Key
Basic Research Program (973 Program). The source also
indicated that an equal amount of funding was provided
by local governments (Personal Communication, Anony-
mous, October 2007), yielding a total of US$80 million
per year – or about 3% of worldwide public genomics
research funding (Figure 1). Since our source, a senior
official at a publicly funded organization who was not
authorized to speak on such issues, preferred to remain
anonymous, we made numerous attempts to contact mul-
tiple individuals at the above organizations and the
United States NSF-Beijing for attributable data; unfortu-
nately, we were unsuccessful in gathering the data via
those means.
Germany
In Germany, the Federal Ministry for Education and
Research (Budesministerium fuer Bildung und Forschung,
BMBF) coordinates the R&D initiative for the federal gov-
ernment [61]. Analysis of genomics research funding by
Germany, which provided about 2% of the total (Figure
1), revealed that genomics research peaked in 2003;
although 2006 levels were slightly higher than 2004 and
2005 levels, by all measures (Tables 4, 5, and 6). The
National Genome Research Network (Nationalen
Genomforschungsrutz, NGFN), established in 2001 and
included in this world survey, is one of two organizations
to which BMBF supplied funds for both scientific research
and research into the ethical, legal, and economic impacts
of genomics [62]. The other organization is the German
Human Genome Project [62], which was discontinued in
June 2004 [63] and not included in this survey. Another
public funder, the German Research Foundation (Deut-
sche Forschungsgemeinschaft, DFG), which promotes
research at universities and other publicly financed
research institutions [64], did not respond to the survey.
The Netherlands
The primary funder of genomics research in the Nether-
lands is the Netherlands Genomics Initiative (NGI),
which was established by the Netherlands Organization
for Scientific Research (Nederlandse Organisatie voor
Wetenschappelijk Onderzoek; NWO) and five govern-
ment ministries in 2001. The NGI was created to combine
existing strengths into one initiative composed of core
activities (Centres of Excellence, Innovative Clusters,
Technology Centres, Exceptional Talent, International
Research Consortiums, and Innovate Genomics Clusters)
and research programs [31]. Netherlands genomics
research funding was about 2% of the total in 2006 (Fig-
ure 1); but its rank jumped from seventh (Table 4) to fifth
when adjusting for genomics intensity (Tables 5 and 6).Page 13 of 18
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In South Korea, which accounted for 2% of total genomics
research funding in 2006 (Figure 1), the Ministry of Sci-
ence and Technology (MOST) is the central agency for
national science and technology development, including
support for basic and applied research and development
supported by the government [65], making it likely that
the values reported here represent nearly all of the coun-
try's genomic research funding. Although South Korea's
funding for genomics research has been increasing stead-
ily since 2004, the incoming president has pledged to
eliminate four government ministries, possibly merging
the MOST with the Ministry of Education, which may
weaken it [66].
Ireland
According to the Office of Science and Technology of the
Ireland Department of Enterprise, Trade, and Employ-
ment, three government agencies are responsible for most
of the genomics funding in Ireland (Personal Communi-
cation, Helen Dixon, August 2006). These three agencies
– the Higher Education Authority, the Science Founda-
tion, and the Health Research Board – are included in this
survey. The Irish government has recently increased its
investment in R&D with the goal of meeting or exceeding
the average R&D investment of European Union countries
[67]. Indeed, Ireland appears to place a high priority on
genomics research since its rank increases dramatically
from ninth (Table 4) to first in funding per capita and per
GDP (Tables 5 and 6). However, Ireland's spending on
genomics research is likely to be overestimated, since the
values reported by the Higher Education Authority
include all biomedical/bioscience projects (because each
program lists some degree of genomics research; Personal
Communication, Sorcha Carthy, August 2006). Of note,
the Science Foundation indicated that genomics research
represents approximately 19% of its bio-related funding
to date (Personal Communication, Tracey Moloney, Sep-
tember 2006). Applying the same percentage to the bio-
science funding of Higher Education Authority would
decrease total genomics research funding in Ireland to
US$9.4 – 16.8 million per year, corresponding to US$2 –
4 per capita.
Spain
Genoma España is the Foundation for the Development
of Genomic and Proteomic Research, and is backed by the
Spanish State through the Ministry of Health and Con-
sumer Affairs (Ministerio de Sanidad y Consumo), and
the Ministry of Education and Science (Ministerio de Edu-
cacion y Ciencia) [68]. Genoma España is one of four
main funding centers in biotechnology, along with the
Center for Development of Industrial Technology (Centro
para el Desarollo Tecnologio Industrial) in the Ministry of
Industry, Trade and Tourism (Ministerio de Industria, Tur-
ismo y Comercio), the Instituto de Salud Carlos III in the
Ministry of Health and Consumer Affairs, and the Minis-
try of Education and Science [69]. Although Spain is a
low-ranked by all measures (Tables 4, 5, and 6), it has
recently developed new government programs to increase
total R&D from 1.25% of GDP to 2% of GDP by 2010 [69-
71], indicating that Spain's overall investment in genom-
ics research is likely to increase.
Australia
In Australia, the National Health and Medical Research
Council (NHMRC) is the "peak body" for supporting
health and medical research [72] and provided US$6 – 8
million for genomics research (2003 – 2006; Table 1).
Two other organizations that fund genomics research, the
Australian Research Council, and the Australian Genome
Research Facility, did not respond to the survey. Australia
has initiated a National Collaborative Research Infrastruc-
ture Strategy, which will include funding for genomics
research [73], and could serve to increase the amount of
funding supplied for genomics research, as it currently
accounts for less than 1% of the total funding (Figure 1).
South Africa
The government agency responsible for supporting basic
and applied research in South Africa is the National
Research Foundation [74], while most government fund-
ing for health research is funded through the Medical
Research Council [75]. The amount of genomics research
funded by South Africa was US$2.2 – 3.0 million for both
of these government funders (2003 – 2006; Table 4); the
Centre for Research on Science & Technology did not
respond to our survey.
New Zealand
The three main funders of genomics research in New Zea-
land are the Foundation for Research in Science and Tech-
nology (FRST), the Royal Society, and the Health Research
Council (Personal Communication, Kate McDavitt,
August 2006). Only FRST, which represents half of the
New Zealand government-funded R&D [76], responded.
Unfortunately, although FRST was very willing to provide
funding information, staff were unable to segregate their
funded research into a category that represented only
genomics research, and we could not include them in the
tabulation.
Middle-income countries with developing genomics sectors
As described by the World Health Organization, genomics
research is beginning to occur in developing countries and
regions such as Brazil, China, India, and the Asia-Pacific
Region [77]. We contacted organizations in Argentina
(Agencia Nacional de Promocion Cientifica y Tecnolog-
ica, and Consejo Nacional de Investigationes Cientificas y
Tecnicas), India (Ministry of Science and TechnologyPage 14 of 18
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hardt Institute of Molecular Biology Russian Genome
Project), as well as the Asian Technology Information Pro-
gram (ATIP) (see Additional File) about their funding of
genomics research, but we received no response other
than an initial response from the ATIP before communi-
cation ceased. The difficulty we encountered in acquiring
an estimate of genomics research expenditures in China is
described above. It will take further work and detailed
case studies to develop a complete report of genomics
research expenditures that are occurring in middle-
income countries and developing regions. One such case
study is in progress for Brazil, where public funders
include the National Council for Scientific and Techno-
logical Development (Conselho Nacional de Desenvolvi-
mento Cientifico e Tecnológico), and the State of São
Paolo Research Foundation (Fundação de Amparo à
Pesquisa do Estado de São Paulo; FAPESP); preliminary
data indicates that FAPESP funded about US$56 million
(unadjusted for inflation) of genomics research from
1997 – 2007 [78].
Private Funding of Genomics Research
This study represents only government and non-profit
"public" funders of genomics research. The previous sur-
vey in 2000 included private companies, and showed a
roughly 2:1 ratio of private genomics R&D to public fund-
ing (an estimated $1.658 billion from "public" sources
compared to $2.016 billion for publicly traded genomics
firms and another $800 million to $1 billion from mem-
bers of the Pharmaceutical Research and Manufacturers
Association [research-intensive pharmaceutical and large
biotechnology companies; [26]]). In 2004, an estimated
US$3.2 billion was invested in genomics R&D by 270
genomics firms from 25 countries [27]. Similar to the
public funding of genomics research described here, top
countries for private genomics firms are the United States,
Canada, Germany, France, United Kingdom, and Japan
[27].
Caveats
There are two major caveats to consider when interpreting
the figures reported in this world survey. First, many
organizations and countries are not included in this study,
either because we did not know to contact them or
because they did not respond. Thus, the full amount of
genomics research funded by public sources is certainly
higher than the estimates reported in this study.
Second, the values provided by each organization are esti-
mates, according to each organization's own definition of
genomics research, which is not uniform across all organ-
izations. For example, organizations might have included
some genetics research in their genomics research esti-
mates. Consider the NHGRI and the CDC definition of
genomics as "the study of all of [a person's genes]" includ-
ing "interactions of those genes with each other and the
person's environment" [2,79]). Interestingly, another US
government agency, the Environmental Protection
Agency, although not queried in this world survey, pro-
vides a definition of genomics, "the study of genes and
their function" [80], that is almost exactly the definition
provided for genetics by the NHGRI [79] and in the litera-
ture [[17,27] and references therein]. We note, however,
that we only included values from organizations that were
able to respond to our query for genomics research; organ-
izations stating that they were not able to extract informa-
tion from their funding databases for genomics research
were not included.
Conclusion
Although this survey is an estimate of funding for genom-
ics research, and necessarily fuzzy and approximate, it rep-
resents the only attempt to perform such a survey to our
knowledge, and therefore provides patterns and trends as
a rough indicator for planning among researchers, science
administrators, policymakers, and the general public.
This world survey would not have been possible had we
tried to gather funding information for genomics research
according to a strict and consistent definition. If govern-
ments and private funders believe that genomics as a
funding category is permanent and worth retaining as a
separate category for analysis, it will need a more uniform
definition. This is particularly relevant for the NIH, the
world's largest biomedical research funder, which, except
for two constituent institutes, (the NHGRI and the NCI)
does not track funding of genomics research. And these
two Institutes report widely different figures for genomics
as a fraction of genetics research, reflecting some real dif-
ferences but probably also reflecting different definitions
of genomics research. Furthermore, the closest research
category that the NIH does track, genetics, is not defined
centrally.
The NIH is in the process of developing a "portfolio anal-
ysis" web-accessible tool that will allow the public to
access information about NIH projects by research area,
the definitions of which will be "laboriously crafted with
input from hundreds of scientists" [81]. The effort that is
being expended to create this tool indicates the impor-
tance that the NIH places upon appropriately categorizing
public expenditures by research area. If genetics, genom-
ics, or both are deemed important categories in which to
monitor science trends and for budget planning, then it
would be worthwhile to invest in a process to clarify defi-
nitions, and the NIH's definition might well become a
world standard.Page 15 of 18
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of genomics: "the identification, characterization and
quantification of all genes involved in a particular path-
way, organelle, cell, tissue, organ or organism that can be
studied in concert to provide accurate and comprehensive
data about that system" (Personal Communication, Wes-
ton Ricks, June 2006). This is a detailed definition that
encompasses and expands upon the definition of genom-
ics already in use by the NHGRI and the CDC (see above).
If the NIH includes genomics as a research area in its new
portfolio analysis tool, the NCI definition could serve as a
starting point for the development of a trans-NIH defini-
tion of genomics research.
Genomics research has become incorporated into scien-
tific and medical research, and is beginning to be applied
in medicine and commerce. Genomics captures the atten-
tion of the general public because of its technological
power to study the structure and function of DNA, with
the consequent potential to reveal intimate details about
individuals, populations, and associations between geno-
type and phenotype.
The amount of funding provided for genomics research is
of interest to both scientific and lay communities world-
wide. This world survey indicates that overall public fund-
ing for genomics research, as a minimum estimate,
averaged around US$2.9 billion annually (2003 – 2006).
Government and nonprofit funding of genomics research
is likely to comprise between one-third and one-half of
the total funding (where the remainder is for-profit pri-
vate funding), based on the worldwide distribution of
funding for health research (where government and non-
profit funding for health research account for 45% and
7% of worldwide funding for health research, respectively
[82], and based on separate surveys of private genomics
R&D in 2000 [26] and [27]).
Methods
This survey was conducted by email and telephone. Gov-
ernment and nonprofit contacts were assembled by con-
tacting known genome research administrators and
scientists, adding contacts from public information and
genome websites, and building on the previous world sur-
vey of genomics research begun in 2000 [26].
Generally, contacts were emailed the survey question,
which asked respondents to identify the total amount of
funding that their organizations supplied for genomics
research each year (2003 – 2006), with the understanding
that estimates were acceptable. In some cases, initial con-
tact was by phone. Follow-up email correspondence often
occurred, with the most effort being expended on procur-
ing figures from the largest public funders. In a few cases,
such as China, we were able to obtain funding informa-
tion only from intermediaries familiar with science budg-
ets because of their role in national planning and as
performers of genomics research.
Data were requested by fiscal year and are reported in the
tables for the calendar year that encompassed most of that
fiscal year. Specifically, the calendar year at the beginning
of the fiscal year was used when the fiscal year began on
April 1, while the calendar year at the end of the fiscal year
was used when the fiscal year began on October 1. When
funding amounts were supplied in a currency other than
US$, they were converted to US$, using the purchasing
power parity (PPP) indices provided by the OECD [83],
except for South Africa, where implied PPP indices were
calculated from International Monetary Fund (IMF) data
[84].
To determine per capita genomics funding, the amount of
funding per country (in US$) was divided by the esti-
mated population in the middle of the year, as provided
by OECD for 2003–2005 [85]. The population data for
2006 were gathered from the Population Reference
Bureau 2006 Data Sheet for all countries [86]. To deter-
mine genomics funding per GDP, the amount of funding
per country (in US$) was divided by the GDP (in US$) for
each year, provided by the IMF [84].
Rankings listed in the tables were determined by ordering
2006 values, except in the two instances where the 2006
data were not reported. In those cases, an average of the
three previous years determined the ranking order for
2006.
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